IGF2BP3 and neoplasm: In addition, MCM3 and IGF2BP3 exhibited consistent upregulation in tumor tissues compared to NATs in six multiple cancer proteomic databases [23,36,37,38,39,40] (p < 0.05, log2FC > 0.5) (Supplementary Figure S5b and Table S4c).